This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Guixian Chen: Innovator in Anti-Tubercular Drug Formulation
Introduction
Guixian Chen is a notable inventor based in Fuyang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of anti-tubercular drugs. His innovative approach has led to advancements that enhance the stability and bioavailability of essential medications.
Latest Patents
Guixian Chen holds a patent for an oral solid formulation of a compound anti-tubercular drug. This patent, which includes the preparation method, features a unique combination of active ingredients: rifampicin, isoniazid, pyrazinamide, and ethambutol hydrochloride. The formulation is designed as a coated tablet with a coated core or a coated three-layer tablet, ensuring that rifampicin and isoniazid do not come into direct contact. This innovative design not only improves the stability of the compound preparation but also enhances the bioavailability of rifampicin. He has 1 patent to his name.
Career Highlights
Throughout his career, Guixian Chen has worked with prominent companies in the pharmaceutical and technology sectors. Notably, he has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he contributed to the development of pharmaceutical formulations. Additionally, he has experience with ZTE Corporation, further showcasing his diverse expertise.
Collaborations
Guixian Chen has collaborated with several professionals in his field, including Qilan Zheng and Chao Xu. These collaborations have likely contributed to his innovative work and the successful development of his patented formulations.
Conclusion
Guixian Chen's contributions to the field of anti-tubercular drug formulation highlight his innovative spirit and dedication to improving pharmaceutical solutions. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile